JPH0441156B2 - - Google Patents

Info

Publication number
JPH0441156B2
JPH0441156B2 JP58127033A JP12703383A JPH0441156B2 JP H0441156 B2 JPH0441156 B2 JP H0441156B2 JP 58127033 A JP58127033 A JP 58127033A JP 12703383 A JP12703383 A JP 12703383A JP H0441156 B2 JPH0441156 B2 JP H0441156B2
Authority
JP
Japan
Prior art keywords
methanol
ylcarbonyl
glycinamide
group
prolyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58127033A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5931746A (ja
Inventor
Peetaa Aruburehito Hansu
Kuraisukotsuto Horusuto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of JPS5931746A publication Critical patent/JPS5931746A/ja
Publication of JPH0441156B2 publication Critical patent/JPH0441156B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58127033A 1982-07-14 1983-07-14 ペプチドのｎ―アシル誘導体 Granted JPS5931746A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19823226241 DE3226241A1 (de) 1982-07-14 1982-07-14 N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer
DE3226241.8 1982-07-14

Publications (2)

Publication Number Publication Date
JPS5931746A JPS5931746A (ja) 1984-02-20
JPH0441156B2 true JPH0441156B2 (member.php) 1992-07-07

Family

ID=6168357

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58127033A Granted JPS5931746A (ja) 1982-07-14 1983-07-14 ペプチドのｎ―アシル誘導体

Country Status (6)

Country Link
US (1) US4610817A (member.php)
EP (1) EP0099057B1 (member.php)
JP (1) JPS5931746A (member.php)
AT (1) ATE30238T1 (member.php)
CA (1) CA1257748A (member.php)
DE (2) DE3226241A1 (member.php)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113219D0 (en) * 1991-06-19 1991-08-07 Fujisawa Pharmaceutical Co Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
US6767897B2 (en) * 1994-05-04 2004-07-27 Innapharma, Inc. Therapeutic uses of tri-, tetra-, penta-, and polypeptides
US5767083A (en) * 1994-05-04 1998-06-16 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent
US5589460A (en) * 1994-05-04 1996-12-31 Innapharma, Inc. Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1085916A (en) * 1964-12-01 1967-10-04 Nat Res Dev O-acyl hydroxylamines
US3795738A (en) * 1972-12-26 1974-03-05 Abbott Lab Use of l-propyl l-leucyl glycine amide to treat parkinson's disease
US4018912A (en) * 1975-07-28 1977-04-19 Ayerst Mckenna And Harrison Ltd. Tripeptide derivatives with central nervous system activity and preparation thereof
US4041023A (en) * 1976-04-14 1977-08-09 Hoffmann-La Roche Inc. Labelled peptides
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
WO1980000216A1 (en) * 1978-07-10 1980-02-21 Univ Illinois Inhibition by peptides of tolerance to and dependence on morphine
DE2933713A1 (de) * 1979-08-21 1981-03-12 Bergwerksverband Gmbh, 4300 Essen Verfahren zur reduktion von so (pfeil abwaerts)2 -reichgasen zu elementarem schwefel
US4278595A (en) * 1979-12-10 1981-07-14 Vega Laboratories, Inc. Orally active MIF analogs with an effect on the central nervous system
US4395401A (en) * 1981-09-09 1983-07-26 Smithkline Beckman Corporation Renally active dipeptides

Also Published As

Publication number Publication date
JPS5931746A (ja) 1984-02-20
DE3226241A1 (de) 1984-01-26
DE3374066D1 (en) 1987-11-19
ATE30238T1 (de) 1987-10-15
EP0099057A3 (en) 1984-09-12
EP0099057A2 (de) 1984-01-25
EP0099057B1 (de) 1987-10-14
US4610817A (en) 1986-09-09
CA1257748A (en) 1989-07-18

Similar Documents

Publication Publication Date Title
US6410548B2 (en) Spiropiperidine derivatives as melanocortin receptor agonists
KR880000890B1 (ko) 두고리 화합물의 제조방법
JPH06340691A (ja) ペプチド類
WO1999064002A1 (en) Spiropiperidine derivatives as melanocortin receptor agonists
NO159017B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
JPH0132239B2 (member.php)
EP0198898A1 (en) DIPEPTIDE COMPOUNDS HAVING PHARMACEUTICAL ACTIVITY AND COMPOSITIONS CONTAINING SAME.
JPS6120544B2 (member.php)
JPH04253995A (ja) 新規ペプチド化合物
NO861141L (no) Fremgangsmaate ved fremstilling av therapeutisk virksomme n,n[-dialkylguanidino-dipeptider.
US4218474A (en) Derivatives of L- and DL-4-hydroxyphenylglycine
JPH0811746B2 (ja) 新規ペプチド化合物
US4906615A (en) Substituted dipeptides as inhibitors of enkephalinases
NO832648L (no) Nye derivater av 2-aza-bicyclo(2.2.2)oktan-3-karbonsyre, fremgangsmaate til deres fremstilling, middel inneholdende dette og deres anvendelse samt 2-aza-bicyclo(2.2.2)oktan-3-karbonsyre som mellomstoff og fremg. til deres fremst
US5098888A (en) New heterocyclic tripeptide compounds
JP2000327575A (ja) ジケトピペラジン誘導体含有炎症疾患治療剤および新規なジケトピペラジン誘導体
US4721726A (en) Substituted dipeptides as inhibitors of enkephalinases
EP0077274B1 (en) 3-amino-2-hydroxy-4-phenylbutanoic acid derivatives and pharmaceutical composition containing the same
JPH0441156B2 (member.php)
AU617224B2 (en) Pyrrolidone-2-carboxylic acid derivatives having a psychotropic action
US5359087A (en) Bioactive quisqualic acid analogs
US4278595A (en) Orally active MIF analogs with an effect on the central nervous system
US5286715A (en) New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use
US4610818A (en) N-acyl derivatives of dipeptides, their preparation and their use in the therapy of disorders, and agents for this purpose
JPH031319B2 (member.php)